NTI ADDAE KWAME W,WALDO MICHAEL,O NEIL SIMON ADAM,VAN ALSTEN JOHN GREGG,MACIKENAS DAINIUS,MUDUNURI PRAVEEN,SHI YI,LEDEBOER MARK WILLEM,JURKAUSKAS VALDAS,MEDEK ALES,JONES STEVEN,BYRN RANDAL,ASMAL MOHAM
申请号：
IN201637015737
公开号：
IN201637015737A
申请日:
2016.05.05
申请国别(地区):
IN
年份:
2016
代理人:
摘要：
Polymorphic forms of Compound (1) or a pharmaceutically acceptable salt thereof, wherein Compound (1) is represented by the following structural formula: are Form A of HCl salt of Compound (1)�1/2?20, Form F of HCl salt of Compound (1)�3?20, Form D of HCl salt of Compound (1), Form A of Compound (1), and Form A of tosylate salt of Compound (1). Such polymorphic forms are employed for treating influenza, inhibiting the replication of influenza viruses, or reducing the amount of influenza viruses in a biological sample or in a subject.
